Ethyl acetate extract |
25, 50, and 100 mg/mL |
-
-
Method: MTT 1 assay, AO/EtBr staining, DNA fragmentation assay
-
-
Cells: A375, A549, HeLa, HT29.
|
-
-
Concentration-dependent decrease in cell viability against all tested cell lines.
-
-
Highest activity against A549 cell line via the induction of apoptosis.
-
-
Treated cells exhibited morphological changes including shrinkage, distortion, and rounded.
|
[16] |
Methanol/chloroform extract |
100–1000 mg/mL |
-
-
Method: SRB 2 assay.
-
-
Cells: MCF-7, DU-145, HeLa, SKOV-3), PANC-1.
|
-
-
Only the crude extract showed a potent cytotoxicity against SKOV-3 cell (IC50 0.52 mg/mL)
-
-
Crude extract exhibited the highest cytotoxic activity against MCF-7 cells (IC50 2.30 mg/mL) among other treatments.
|
[15] |
Chloroform fraction |
100–1000 mg/mL |
-
-
Method: SRB assay.
-
-
Cells: MCF-7, DU-145, HeLa, SKOV-3), PANC-1.
|
|
[15] |
FAs content |
100–1000 mg/mL |
-
-
Method: SRB assay.
-
-
Cells: MCF-7, DU-145, HeLa, SKOV-3), PANC-1.
|
|
[15] |
USM 3 content |
100–1000 mg/mL |
-
-
Method: SRB assay.
-
-
Cells: MCF-7, DU-145, HeLa, SKOV-3), PANC-1.
|
|
[15] |
Ethanolic extract of the leaves |
100 and 200 μg/mL |
-
-
Method: proliferation assays (MTT and cell cycle analysis), cancer phenotype assay (migration, invasion, aggregation, and adhesion), and in ovo assay.
-
-
Cells: MDA-MB-231.
|
-
-
Dose- and time-dependent decrease in proliferation by inducing cell cycle arrest and activating apoptosis.
-
-
Attenuation of cancer metastasis by inhibiting cell migration, invasion, adhesion, aggregation, and angiogenesis.
-
-
Downregulation of STAT3 signaling pathway.
|
[56] |